Teva Beats Patent Claims Over Uceris Generic

Law360, Chicago (November 1, 2017, 9:45 PM EDT) -- Teva and another generic-drug maker have beaten a patent infringement suit in Delaware federal court from Irish pharmaceutical company Cosmo Technologies Ltd. over a planned generic version of colitis medication Uceris.

U.S. District Judge Leonard P. Stark issued a final order Friday freeing Teva Pharmaceutical Industries Ltd. and New Jersey-based Alvogen Pine Brook LLC from claims they infringed patents for 9-milligram budesonide extended-release tablets. While the judge's memorandum was sealed, the generics makers had argued that the patent was invalid as obvious.

"We are pleased with...
To view the full article, register now.